慢性疼痛的成本 - 长期估计
Audun Stubhaug1,2, Johan Liseth Hansen3,4, Sara Hallberg3
1Department of Pain Management and Research, Oslo University Hospital, Oslo, Norway.
European journal of pain (London, England)
|January 12, 2024
概括
慢性疼痛显著影响人们的福祉,并造成巨大的经济成本,生产力损失占疼痛负担的80%. 这项研究量化了与慢性疼痛相关的大量医疗保健和工作缺勤费用.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 慢性疼痛会影响工作,功能和生活质量,降低整体幸福感.
- 尽管慢性疼痛普遍存在,但研究和政策关注度有限,社会成本基本上是未知的.
- 这项研究量化了慢性疼痛和没有慢性疼痛的人的长期医疗保健和工作缺席成本.
研究的目的:
- 为了估计慢性疼痛在一般人群中的经济负担.
- 为了区分患有慢性疼痛和没有慢性疼痛的人之间的医疗保健使用和生产力损失成本.
- 为政策和公众了解慢性疼痛对社会影响提供信息.
主要方法:
- 利用了来自挪威两项人口健康研究 (HUNT3和Tromsø6) 的数据.
- 根据2008年健康研究中自我报告的答案,定义了慢性疼痛.
- 将参与者数据链接到四个国家医疗保健资源使用和工作缺席登记册.
主要成果:
- 36%的研究人口 (63,782个人) 自报慢性疼痛.
- 从2010年至2016年,每位患有慢性疼痛的个人累计成本差异为55,003.3欧元.
- 据估计,慢性疼痛每年的负担占GDP的4%,其中80%归因于生产力下降.
结论:
- 这项研究是首次利用相关的行政和调查数据估计慢性疼痛的经济负担.
- 慢性疼痛的年度成本估计为120亿欧元,相当于GDP的4%.
- 研究结果强调,需要对慢性疼痛群体的医疗保健使用和生产力损失有更好的理解和干预.
相关概念视频
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Opioid Analgesics: Synthetic and Semisynthetic Opioids
300
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
300


